Adherence to a new oral anticoagulant treatment prescription: dabigatran etexilate

References

• OrenskyIAHoldfordDAPredictors of noncompliance with warfarin therapy in an outpatient anticoagulation clinicPharmacotherapy2005251218011801816305299
   PubMed Web of Science ®Google Scholar
• Loghman-AdhamMMedication noncompliance in patients with chronic disease: issues in dialysis and renal transplantationAm J Manag Care20039215517112597603
   PubMed Web of Science ®Google Scholar
• LaporteSQuenetSBuchmuller-CordierAReynaudJTardy-PoncetBThirionCCompliance and stability of INR of two oral anticoagulants with different half-lives: a randomised trialThromb Haemost200389345846712624628
   PubMed Web of Science ®Google Scholar
• ScodittiUBuccinoGPPiniMPattaciniCManciaDRisk of acute cerebrovascular events related to low oestrogen oral contraceptive treatmentItal J Neurol Sci1998191151910935854
   PubMedGoogle Scholar
• BarcellonaDVanniniMLFenuLBalestrieriCMarongiuFWarfarin or acenocoumarol: which is better in the management of oral anticoagulants?Thromb Haemost19988068999029869157
   PubMed Web of Science ®Google Scholar
• Van der MeerFJBrietEVandenbrouckeJPSramekDIVersluijsMHRosendaalFRThe role of compliance as a cause of instability in oral anticoagulant therapyBr J Haematol19979848939009326185
   PubMed Web of Science ®Google Scholar
• HaynesRBTaylorDWSackettDLCompliance in Health CareBaltimoreJohns Hopkins University Press1979145156
   Google Scholar
• ArnstenJHGelfandJMSingerDEDeterminants of compliance with anticoagulation: A case-control studyAm J Med1997103111179236480
   PubMed Web of Science ®Google Scholar
• CramerJAMattsonRHPreveyMLScheyerRDOuelletteVLHow often is medication taken as prescribed? A novel assessment techniqueJAMA198926122327332772716163
   PubMed Web of Science ®Google Scholar
• PullarTBirtwellAJWilesPGHayAFeelyMPUse of a pharmacologic indicator to compare compliance with tablets prescribed to be taken once twice, or three times dailyClin Pharmacol Ther19884455405453180635
   PubMed Web of Science ®Google Scholar
• LorentzAEckardtKOsswaldPKruseCPerioperative plasma erythropoietin levels in hip arthroplastyAnn Hematol19946831171248167177
   PubMed Web of Science ®Google Scholar
• PaesAHBakkerASoe-AgnieCJImpact of dosage frequency on patient complianceDiabetes Care19972010151215179314626
   PubMed Web of Science ®Google Scholar
• HorowitzRIHorowitzSMHAdherence to treatment and health outcomesArch Intern Med1993153186318688250647
   PubMedGoogle Scholar
• CramerJAFeedback on medication dosing enhances patient complianceChest199310423333348339613
   PubMed Web of Science ®Google Scholar
• TebbiCKTreatment compliance in childhood and adolescenceCancer1993157110 Suppl344134498490895
   PubMed Web of Science ®Google Scholar
• MooreSBSwenkePKFossMLRandJACabanelaMEKavanaghBSimplified enrollment for autologous transfusion: automatic referral of presurgical patients for assessment for autologous blood collectionsMayo Clin Proc19926743233271548946
   PubMed Web of Science ®Google Scholar
• RosencherNVielpeauCEmmerichJFagnaniFSamamaCMVenous thromboembolism and mortality after hip fracturesurgery: the escorte studyJ Thromb Haemost200532006201416102107
   PubMed Web of Science ®Google Scholar
• RosencherNVielpeauCEmmerichJFagnaniFSamamaCMVenous thromboembolism and mortality after hip fracture surgery: the ESCORTE studyJ Thromb Haemost2005392006201416102107
   PubMed Web of Science ®Google Scholar
• KehletHMultimodal approach to control postoperative pathophysiology and rehabilitationBr J Anaesth1997786066179175983
   PubMed Web of Science ®Google Scholar
• FossNBKristensenMTKehletHPrediction of postoperative morbidity, mortality and rehabilitation in hip fracture patients: the cumulated ambulation scoreClin Rehabil200620870170816944827
   PubMed Web of Science ®Google Scholar
• LiebermanDFrigerMLiebermanDInpatient rehabilitation outcome after hip fracture surgery in elderly patients: a prospective cohort study of 946 patientsArch Phys Med Rehabil200687216717116442967
   PubMed Web of Science ®Google Scholar
• StenvallMOlofssonBNybergLLundstromMGustafsonYImproved performance in activities of daily living and mobility after a multidisciplinary postoperative rehabilitation in older people with femoral neck fracture: a randomized controlled trial with 1-year follow-upJ Rehabil Med200739323223817468792
   PubMed Web of Science ®Google Scholar
• DevineECMeta-analysis of the effects of psychoeducational care in adults with asthmaRes Nurs Health19961953673768848621
   PubMed Web of Science ®Google Scholar
• BondWSHussarDADetection methods and strategies for improving medication complianceAm J Hosp Pharm1991489197819881928147
   PubMedGoogle Scholar
• WongBSNormanDCEvaluation of a novel medication aid, the calendar blister-pak, and its effect on drug compliance in a geriatric outpatient clinicJ Am Geriatr Soc198735121263794142
   PubMed Web of Science ®Google Scholar
• WittkowskyAKNutescuEABlackburnJMullinsJHardmanJMitchellJOutcomes of oral anticoagulant therapy managed by telephone vs in-office visits in an anticoagulation clinic settingChest200613051385138917099014
   PubMed Web of Science ®Google Scholar
• GeertsWHBergqvistDPineoGFHeitJASamamaCMLassenMRPrevention of venous thromboembolism: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines8th EditionChest20081336 Suppl381S453S18574271
   PubMed Web of Science ®Google Scholar
• DahlOKurthAARosencherNSchneeJClementsDHNoackH150 mg Dabigatran etexilate once daily has a good safety profile and comparable efficacy to enoxaparin for primary prevention of venous thromboembolism after total knee or hip replacement surgery in patients older than 75 years or with reduced renal functionBlood2008supp
   Google Scholar
• DahlOKurthAARosencherNSchneeJClemensANoackHEfficacy and safety profile of dabigatran etexilate compared with enoxaparin for the prevention of venous thromboembolism in moderately renally impaired patients after total knee or hip replacement surgeryBlood2008112(ASH Annual Meeting Abstracts): Abstract 981.
   Web of Science ®Google Scholar
• ErikssonBIDahlODijkVDijkCNFrostickSPKurthA new oral anticoagulant, dabigatran etexilate, is effective and safe in preventing venous thromboembolism after total knee replacement surgery. (The RE-MODEL trial)Blood200610811573
   Web of Science ®Google Scholar
• ErikssonBIDahlOERosencherNKurthAAvan DijkCNFrostickSPDabigatran etexilate versus enoxaparin for prevention of venous thromboembolism after total hip replacement: a randomised, double-blind, non-inferiority trialLancet2007370959194995617869635
   PubMed Web of Science ®Google Scholar
• ErikssonBIDahlOEBullerHRHettiarachchiRRosencherNBravoMLA new oral direct thrombin inhibitor, dabigatran etexilate, compared with enoxaparin for prevention of thromboembolic events following total hip or knee replacement: the BISTRO II randomized trialJ Thromb Haemost20053110311115634273
   PubMed Web of Science ®Google Scholar
• ErikssonBIAgnelliGCohenADahlOMouretPRosencherNSignificantly lower need for blood transfusions associated with post-operatively initiated subcutaneous melagatran/oral ximelagatran compared with enoxaparinThromb Haemost200492242843015269843
   PubMed Web of Science ®Google Scholar